CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN) today announced that the Company plans to release results for the third quarter 2015 on Monday, November 9, 2015, before the opening of the U.S. markets. The Company also will conduct a conference call that day at 11:00 a.m. ET to discuss results and highlights of the third quarter of 2015. The presentation slides to be used during the call will be available on the "Investors" section of the Company's website under the "Overview" tab beginning at 11:00 a.m. ET on Monday, November 9, 2015.
A live webcast of the conference call, presentation and question and answer session will be available on the "Investors" section of the Company's website under the "Overview" tab. To access the live webcast, please log on to POZEN's site approximately 15 minutes prior to the presentation to register and download any necessary audio software. The presentation replay will be available for 90 days after the event.
Conference call details:
Date: Monday, November 9, 2015
Time: 11:00 a.m. ET
Dial-in (U.S.): 877-407-8037
Dial-in (International): 201-689-8037
POZEN Inc. is a specialty pharmaceutical company that to date has historically focused on developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products. Funded by these milestones/royalty streams, POZEN has created a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.
POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit www.pozen.com.